Skip to content

IGM Biosciences up, named as possible takeover target

September 18, 2020

IGM Biosciences (IGMS, +15%) is seeing another sharp gain, leaving technical levels well behind.

Piper Sandler listed the company today as a potential oncology takeover target after Gilead Sciences’ buyout of Immunomedics.

IGMS is among a list of companies with assets Piper says “are both largely de-risked and target high value indications.”

https://seekingalpha.com/news/3615413-igm-biosciencesplus-15-named-possible-takeover-target

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: